mw4me logo
Talk to Us | Subscribe | Investment Advisory
Buy Alpha stocks
Sensex 77580.31
110.64 (-0.14%)

BSE Healthcare Companies

Read More Read Less

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen:- Q: Quality, V: Valuation,PT: Price Trend

Filter
BSE Healthcare companies as on Nov-2024 |
Filter

 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks


Company Name (M.Cap)
DeciZen


CMP


Price
Change


Market
Cap (Cr)


52Week
High


52Week
Low


ROE


P/E


P/BV


EV/
EBITDA


5Y Sales
Gr.(%)


5Y Profit
Gr.(%)
More Info
1
Dishman Carbogen Amcis Ltd
(S)
Q V PT
212.6 18.87% 3,333 282.9
05 Mar, 24		 132.8
04 Jun, 24		 -2.44 0.00 0.60 16.95 4.91 -191.53
2
Neuland Laboratories Ltd
(S)
Q V+ PT
15,547 6.04% 19,816 16,545
12 Nov, 24		 4,928
21 Dec, 23		 26.47 71.13 14.28 46.20 18.51 72.09
3
Shilpa Medicare Ltd
(S)
Q V PT
872.9 5.84% 8,522 960.0
18 Sep, 24		 313.6
10 Jan, 24		 1.19 139.52 3.66 28.58 9.44 -25.55
4
Supriya Lifescience Ltd
(S)
Q V+ PT
643.6 5.28% 5,183 689.6
06 Nov, 24		 240.1
21 Nov, 23		 15.73 32.91 5.72 21.77 15.47 22.62
5
Yatharth Hospital & Trauma Care Services Ltd
(S)
Q V+ PT
609.4 4.22% 5,220 692.9
04 Nov, 24		 360.1
20 Dec, 23		 16.58 57.44 5.95 37.35 32.75 85.94
6
Hikal Ltd
(S)
Q V PT
403.1 4.07% 4,970 415.3
13 Nov, 24		 260.6
13 Mar, 24		 5.97 67.60 4.13 19.47 2.34 -8.26
7
Gland Pharma Ltd
(S)
Q V PT
1,771 3.89% 29,184 2,221
06 Aug, 24		 1,590
24 Oct, 24		 12.20 26.46 3.18 16.14 15.31 17.36
8
Themis Medicare Ltd
(S)
Q V+ PT
272.4 3.59% 2,550 304.3
26 Sep, 24		 152.7
22 Nov, 23		 8.09 69.68 7.84 38.60 15.70 0.00
9
Global Health Ltd
(M)
Q V PT
1,071 3.44% 28,721 1,514
16 Feb, 24		 872.0
24 Nov, 23		 13.50 75.52 9.77 43.89 9.61 38.53
10
Innova Captab Ltd
(S)
Q V+ PT
991.5 3.31% 5,672 1,018
11 Nov, 24		 421.6
04 Jun, 24		 13.71 65.72 7.35 44.71 19.38 24.34
11
Artemis Medicare Services Ltd
(S)
Q V+ PT
278.1 3.19% 3,869 298.4
16 Sep, 24		 140.6
14 Mar, 24		 11.30 68.94 9.81 27.50 9.11 0.00
12
Rainbow Childrens Medicare Ltd
(S)
Q V+ PT
1,650 3.16% 16,755 1,685
04 Nov, 24		 1,016
15 Nov, 23		 18.10 73.60 12.25 33.95 17.90 26.20
13
Thyrocare Technologies Ltd
(S)
Q V PT
976.4 3.01% 5,191 1,002
12 Nov, 24		 533.0
17 Nov, 23		 13.51 61.82 10.63 30.44 7.26 -2.62
14
Mankind Pharma Ltd
(M)
Q V PT
2,606 2.97% 1,04,062 2,883
06 Nov, 24		 1,820
14 Dec, 23		 20.88 51.31 9.65 36.67 19.33 29.77
15
Fortis Healthcare Ltd
(M)
Q V+ PT
639.1 2.95% 48,189 658.4
12 Nov, 24		 352.0
15 Nov, 23		 2.19 305.52 5.31 109.87 12.47 10.01
16
Syncom Formulations (India) Ltd
(S)
Q V+ PT
20.79 2.62% 1,954 27.94
10 Sep, 24		 9.80
21 Nov, 23		 8.22 61.56 6.27 38.57 6.70 11.38
17
AMI Organics Ltd
(S)
Q V+ PT
2,021 2.47% 8,330 2,145
14 Nov, 24		 1,005
14 Mar, 24		 9.16 83.99 6.92 50.39 23.89 15.25
18
Shalby Ltd
(S)
Q V PT
215.1 2.38% 2,322 333.9
24 Jan, 24		 209.3
14 Nov, 24		 10.23 24.42 2.11 12.66 12.40 26.66
19
Healthcare Global Enterprises Ltd
(S)
Q V+ PT
470.9 2.28% 6,569 506.6
05 Nov, 24		 310.1
05 Jun, 24		 2.86 191.41 5.38 28.41 11.41 25.10
20
Indegene Ltd
(S)
Q V+ PT
660.0 2.28% 15,793 736.6
01 Oct, 24		 468.9
04 Jun, 24		 20.85 46.91 6.69 26.20 36.16 85.69
21
Vijaya Diagnostic Centre Ltd
(S)
Q V+ PT
1,038 2.20% 10,691 1,136
08 Nov, 24		 580.8
23 Nov, 23		 20.16 80.64 14.75 39.54 13.36 21.43
22
Blue Jet Healthcare Ltd
(S)
Q V+ PT
528.8 2.16% 9,176 567.9
07 Nov, 24		 319.4
12 Dec, 23		 20.22 54.66 9.93 35.26 0.00 0.00
23
Concord Biotech Ltd
(S)
Q V PT
1,893 2.15% 19,919 2,658
20 Sep, 24		 1,206
20 Nov, 23		 21.38 60.74 12.52 40.02 0.00 0.00
24
Unichem Laboratories Ltd
(S)
Q V+ PT
894.7 2.13% 6,271 949.9
12 Nov, 24		 401.1
28 Dec, 23		 -2.90 326.86 2.66 32.92 8.31 -262.15
25
Gufic Biosciences Ltd
(S)
Q V PT
446.6 1.95% 4,472 501.1
08 Nov, 24		 272.0
15 Nov, 23		 19.85 51.78 8.08 32.11 18.12 25.69
26
Ipca Laboratories Ltd
(M)
Q V+ PT
1,537 1.91% 39,036 1,709
14 Oct, 24		 1,042
15 Nov, 23		 9.67 60.06 5.96 28.71 11.18 4.98
27
Solara Active Pharma Sciences Ltd
(S)
Q V+ PT
758.5 1.89% 3,635 850.0
21 Oct, 24		 292.2
21 Dec, 23		 -35.77 0.00 3.32 -97.41 -1.45 -233.41
28
Eris Lifesciences Ltd
(S)
Q V PT
1,354 1.88% 18,242 1,521
06 Sep, 24		 810.1
13 Mar, 24		 16.24 52.35 6.58 23.99 15.39 6.32
29
Laurus Labs Ltd
(S)
Q V PT
485.8 1.88% 26,095 517.9
10 Sep, 24		 358.7
25 Jan, 24		 3.55 199.05 6.31 35.94 17.07 6.90
30
Jubilant Pharmova Ltd
(S)
Q V+ PT
1,167 1.87% 18,502 1,309
07 Nov, 24		 408.5
15 Nov, 23		 1.36 608.62 8.05 135.28 -25.58 -27.71
31
Glenmark Life Sciences Ltd
(S)
Q V+ PT
1,080 1.86% 13,162 1,335
16 Sep, 24		 620.0
23 Nov, 23		 21.11 31.08 5.19 20.29 20.83 15.64
32
Strides Pharma Science Ltd
(S)
Q V+ PT
1,415 1.84% 13,030 1,675
17 Oct, 24		 473.0
17 Nov, 23		 1.82 172.74 3.70 40.86 6.97 -12.68
33
Poly Medicure Ltd
(S)
Q V+ PT
2,696 1.59% 27,392 3,350
01 Nov, 24		 1,361
31 Jan, 24		 17.84 93.97 10.64 57.94 17.38 29.36
34
Biocon Ltd
(M)
Q V PT
336.1 1.50% 40,334 395.6
17 Sep, 24		 228.3
16 Nov, 23		 8.64 958.06 3.70 103.47 -3.80 31.80
35
Windlas Biotech Ltd
(S)
Q V+ PT
1,024 1.47% 2,137 1,197
06 Nov, 24		 397.9
18 Dec, 23		 13.58 34.92 4.53 20.63 16.97 17.70
36
Narayana Hrudayalaya Ltd
(S)
Q V PT
1,277 1.41% 25,954 1,445
14 Feb, 24		 1,088
04 Jun, 24		 31.41 33.33 8.10 21.29 11.89 68.71
37
Bliss GVS Pharma Ltd
(S)
Q V PT
118.0 1.38% 1,242 148.9
28 Nov, 23		 92.25
04 Jun, 24		 7.12 27.16 1.21 8.26 7.25 4.05
38
Aarti Pharmalabs Ltd
(S)
Q V+ PT
656.4 1.27% 5,910 721.0
29 Aug, 24		 380.6
14 Mar, 24		 13.08 28.66 3.46 16.68 0.00 0.00
39
Krsnaa Diagnostics Ltd
(S)
Q V+ PT
910.9 1.27% 2,955 973.0
11 Nov, 24		 527.5
05 Jun, 24		 7.35 42.68 3.51 15.82 0.00 0.00
40
Alembic Pharmaceuticals Ltd
(S)
Q V PT
1,030 1.07% 20,171 1,296
09 Oct, 24		 710.5
24 Nov, 23		 13.05 31.19 4.13 20.47 9.62 0.22
41
Krishna Institute of Medical Sciences Ltd
(S)
Q V+ PT
559.5 0.99% 22,466 604.0
11 Nov, 24		 350.0
04 Jun, 24		 13.46 93.82 11.24 57.52 11.57 0.00
42
Suven Pharmaceuticals Ltd
(S)
Q V+ PT
1,273 0.76% 32,533 1,359
06 Nov, 24		 559.0
15 Nov, 23		 13.90 133.82 16.44 84.17 22.71 0.00
43
SMS Pharmaceuticals Ltd
(S)
Q V+ PT
262.4 0.75% 2,217 398.0
23 Sep, 24		 114.2
21 Dec, 23		 8.89 37.77 3.71 18.67 8.81 3.05
44
Ajanta Pharma Ltd
(S)
Q V PT
2,860 0.65% 35,596 3,486
12 Sep, 24		 1,853
21 Dec, 23		 23.04 40.68 9.68 26.74 15.41 16.56
45
Indraprastha Medical Corporation Ltd
(S)
Q V+ PT
416.6 0.62% 3,823 489.0
11 Nov, 24		 155.6
14 Mar, 24		 29.11 25.87 7.29 14.23 9.57 33.50
46
Novartis India Ltd
(S)
Q V+ PT
1,061 0.61% 2,621 1,248
26 Sep, 24		 671.8
15 Nov, 23		 10.94 29.98 3.59 16.06 -7.35 20.51
47
Marksans Pharma Ltd
(S)
Q V+ PT
307.4 0.59% 13,928 328.4
20 Sep, 24		 126.0
14 Mar, 24		 10.96 90.74 10.79 61.24 15.00 23.29
48
Natco Pharma Ltd
(S)
Q V PT
1,376 0.55% 24,640 1,638
12 Sep, 24		 752.5
12 Dec, 23		 25.73 12.67 3.45 9.07 13.81 17.86
49
KMC Speciality Hospitals (India) Ltd
(S)
Q V PT
76.82 0.43% 1,272 105.0
24 Jan, 24		 69.00
14 Mar, 24		 23.64 43.94 8.53 25.04 16.59 28.54
50
Advanced Enzyme Technologies Ltd
(S)
Q V PT
380.1 0.40% 4,252 571.1
16 Sep, 24		 311.8
17 Nov, 23		 21.91 43.19 7.06 28.19 10.48 27.93
Prev 1
Screens:
AlphaCases All-Weather Stocks Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks
×
×
Great Decisions Ensure Success

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Dishman Carbogen Amc
212.6018.87%
Neuland Laboratories
15,547.456.04%
Shilpa Medicare
872.905.84%
Supriya Lifescience
643.605.28%
Yatharth Hospital
609.404.22%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Kopran
225.85-6.23%
Astrazeneca Pharma I
6,770.60-5.08%
Kovai Medical Center
5,073.90-3.84%
Sigachi Industries
49.69-2.05%
Lincoln Pharma
614.35-1.89%
View More

News about BSE Healthcare

Mankind Pharma informs about disclosure

Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that as per the terms and conditions of 3 Debenture Trust Deeds executed on October 10, 2024 between the Catalyst Trusteeship and the Company for the issuance of listed, rated, secured, redeemable, transferable non-convertible debentures aggregating to INR 5,000 crores (‘NCDs’) by the Company in 3 Series, 39.68% equity shares of Bharat Serums and Vaccines, wholly owned subsidiary of the Company (‘BSV’) have been pledged in favour of Catalyst Trusteeship as the Common Security Trustee for the benefit of the holders of the NCDs. The detailed disclosure as required SEBI Listing Regulations for aforesaid is enclosed as Annexure I. 

The above information is a part of company’s filings submitted to BSE.

15 Nov, 2024

Global Health - Quaterly Results

The September 2024 quarter revenue stood at Rs. 6646.06 millions, up 13.41% as compared to Rs. 5860.16 millions during the corresponding quarter last year.Profit saw a slight increase of 9.85%to Rs. 1044.66  millions from Rs. 950.95 millions.Operating profit for the quarter ended September 2024 rose to 1738.86 millions as compared to 1545.40 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 6646.06 5860.16 13.41 12760.55 11365.23 12.28 22800.08 19735.37 15.53
Other Income 235.79 203.65 15.78 502.77 476.49 5.52 1028.68 475.92 116.15
PBIDT 1738.86 1545.40 12.52 3328.84 2970.88 12.05 6002.18 4639.56 29.37
Interest 53.68 61.06 -12.09 113.20 124.87 -9.35 244.57 261.61 -6.51
PBDT 1685.18 1484.34 13.53 3215.64 2846.01 12.99 5757.61 4377.95 31.51
Depreciation 249.09 215.42 15.63 482.12 419.70 14.87 870.90 860.88 1.16
PBT 1436.09 1268.92 13.17 2733.52 2426.31 12.66 4886.71 3517.07 38.94
TAX 391.43 317.97 23.10 726.02 613.24 18.39 1277.80 884.60 44.45
Deferred Tax -22.39 -32.48 -31.07 -9.27 -82.71 -88.79 -117.95 -89.02 32.50
PAT 1044.66 950.95 9.85 2007.50 1813.07 10.72 3608.91 2632.47 37.09
Equity 537.09 536.81 0.05 537.09 536.81 0.05 537.01 536.39 0.12
PBIDTM(%) 26.16 26.37 -0.79 26.09 26.14 -0.20 26.33 23.51 11.98
14 Nov, 2024

Ipca Laboratories - Quaterly Results

The revenue for the September 2024 quarter is pegged at Rs. 18109.40 millions, about 8.92% up against Rs. 16626.60 millions recorded during the year-ago period.Net profit surges 50.57% to Rs. 2441.20  millions  from Rs. 1621.30 millions in the quarter ended September 2024.OP of the company witnessed a marginal growth to 4191.10 millions from 3844.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 18109.40 16626.60 8.92 33768.00 31490.00 7.23 61664.60 58146.20 6.05
Other Income 170.00 361.40 -52.96 323.90 793.00 -59.16 1112.90 1111.90 0.09
PBIDT 4191.10 3844.10 9.03 7877.40 7253.00 8.61 13226.70 10230.40 29.29
Interest 172.50 386.40 -55.36 366.70 694.00 -47.16 1206.70 439.20 174.75
PBDT 4018.60 3064.80 31.12 7510.70 6164.10 21.85 10686.40 9791.20 9.14
Depreciation 626.50 613.50 2.12 1239.70 1217.00 1.87 2464.80 2286.30 7.81
PBT 3392.10 2451.30 38.38 6271.00 4947.10 26.76 8221.60 7504.90 9.55
TAX 950.90 830.00 14.57 1788.50 1660.00 7.74 2917.50 2447.90 19.18
Deferred Tax 5.90 -10.00 -159.00 33.50 20.00 67.50 37.40 208.40 -82.05
PAT 2441.20 1621.30 50.57 4482.50 3287.10 36.37 5304.10 5057.00 4.89
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 23.14 23.12 0.10 23.33 23.03 1.28 21.45 17.59 21.91
14 Nov, 2024

Dishman Carbogen Amcis informs about presentation

Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Dishman Carbogen Amcis has informed that it enclosed Presentation on financial result for the second quarter and half year ended 30th September, 2024 to be made to Analyst and Investors. The aforesaid presentation is also being hosted on the website of the Company, www.imdcal.com in accordance with the Regulations 46 and 62 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


14 Nov, 2024

Dishman Carbogen Amc - Quaterly Results

A decent increase of about 56.21% in the turnover to Rs. 932.90 millions was observed for the quarter ended September 2024. The turnover stood at Rs. 597.20 millions during the similar quarter previous year.The Total Profit for the quarter ended September 2024 of Rs. 142.50 millions grew from Rs.-57.80 millionsOperating profit surged to 373.30 millions from the corresponding previous quarter of 357.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 932.90 597.20 56.21 1967.00 1292.70 52.16 3273.50 4025.50 -18.68
Other Income 239.30 387.10 -38.18 355.20 531.50 -33.17 630.50 521.60 20.88
PBIDT 373.30 357.90 4.30 638.20 452.10 41.16 698.50 599.20 16.57
Interest 155.90 174.20 -10.51 313.20 351.80 -10.97 681.90 579.20 17.73
PBDT 217.40 153.20 41.91 325.00 69.80 365.62 -13.90 0.00 0.00
Depreciation 163.00 245.80 -33.69 326.20 492.70 -33.79 1016.10 962.00 5.62
PBT 54.40 -92.60 -158.75 -1.20 -422.90 -99.72 -1030.00 -962.00 7.07
TAX -88.10 -34.80 153.16 -109.00 -151.80 -28.19 -265.90 -373.30 -28.77
Deferred Tax -88.10 -34.80 153.16 -109.00 -151.80 -28.19 -376.50 -373.30 0.86
PAT 142.50 -57.80 -346.54 107.80 -271.10 -139.76 -764.10 -588.70 29.79
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 40.02 59.93 -33.23 32.45 34.97 -7.23 21.34 14.89 43.35
13 Nov, 2024

Shilpa Medicare - Quaterly Results

The turnover zoomed to Rs. 1296.82 millions, up 73.80% for the September 2024 quarter as against Rs. 746.14 millions during the year-ago period.The company almost doubled its revenue to Rs. 304.89 millions  from Rs. 66.03 millions in the quarter ended September 2024.Operating Profit saw a handsome growth to 643.27 millions from 300.52 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1296.82 746.14 73.80 2258.01 1583.55 42.59 3097.87 2477.02 25.06
Other Income 214.69 227.61 -5.68 529.23 435.43 21.54 891.16 686.44 29.82
PBIDT 643.27 300.52 114.05 1197.31 661.73 80.94 1154.08 246.42 368.34
Interest 11.90 51.78 -77.02 31.39 119.38 -73.71 172.57 208.25 -17.13
PBDT 626.66 246.62 154.10 1156.61 476.86 142.55 877.00 -117.30 -847.66
Depreciation 120.20 126.67 -5.11 243.22 249.30 -2.44 496.11 465.48 6.58
PBT 506.46 119.95 322.23 913.39 227.56 301.38 380.89 -582.78 -165.36
TAX 201.57 53.92 273.83 325.00 82.53 293.80 111.52 -87.93 -226.83
Deferred Tax -4.89 -5.36 -8.77 6.50 4.45 46.07 -1.35 -4.27 -68.38
PAT 304.89 66.03 361.74 588.39 145.03 305.70 269.37 -494.85 -154.43
Equity 97.79 86.80 12.66 97.79 86.80 12.66 86.80 86.80 0.00
PBIDTM(%) 49.60 40.28 23.16 53.03 41.79 26.89 37.25 9.95 274.48
13 Nov, 2024
Track Now: 5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds
Trending on MoneyWorks4Me: Future Upside Vs Past Performance in Funds Stock Reasearch Reports How many stocks to own in portfolio? Why PE Ratio is important? How to Choose Good Stocks?

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 6,177 14,293 33.66 18.64 21.03 51.69
Glaxosmithkline Pharmaceuticals Ltd. (M) Very Good 2,457 41,584 61.60 24.86 35.02 37.27
Abbott India Ltd. (M) Very Good 27,347 58,403 45.46 16.59 31.62 34.87
Gujarat Themis Biosyn Ltd. (S) Very Good 294.1 3,205 60.81 14.34 42.34 33.76
Procter & Gamble Health Ltd. (S) Very Good 5,144 8,517 39.12 13.73 24.03 33.46

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Jubilant Pharmova Ltd. (S) Somewhat Good 1,167 18,502 182.0
Suven Pharmaceuticals Ltd. (S) Very Good 1,273 32,533 120.3
Piramal Pharma Ltd. (S) Not Good 258.4 34,257 115.0
Glenmark Pharmaceuticals Ltd. (M) Somewhat Good 1,532 43,429 111.4
Poly Medicure Ltd. (S) Very Good 2,696 27,392 89.92
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Indegene Ltd. (S) Very Good 660.0 15,793 46.91 6.69 26.20 36.16
Gujarat Themis Biosyn Ltd. (S) Very Good 294.1 3,205 60.81 14.34 42.34 32.84
Yatharth Hospital & Trauma Care Services Ltd. (S) Very Good 609.4 5,220 57.44 5.95 37.35 32.75
Max Healthcare Institute Ltd. (M) N/A 1,006 98,283 92.81 11.17 55.40 26.17
Sun Pharma Advanced Research Company Ltd. (S) Not Good 197.2 6,400 0.00 -80.32 -15.86 24.99

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Yatharth Hospital & Trauma Care Services Ltd. (S) Very Good 609.4 5,220 57.44 5.95 37.35 85.94
Indegene Ltd. (S) Very Good 660.0 15,793 46.91 6.69 26.20 85.69
Neuland Laboratories Ltd. (S) Somewhat Good 15,547 19,816 71.13 14.28 46.20 72.09
Narayana Hrudayalaya Ltd. (S) Very Good 1,277 25,954 33.33 8.10 21.29 68.71
Gujarat Themis Biosyn Ltd. (S) Very Good 294.1 3,205 60.81 14.34 42.34 56.41

Want to build you portfolio with best stocks today?

Check Now!
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta whatsapp
Address: The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | ODR | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.